abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

29 Jan 2007

Author:
Pongpiphat Banchanont, Reuters

Thailand Allows Copycat Pharmaceuticals

Thailand's army-appointed government confirmed on Monday it approved a cheap, copycat version of a blockbuster heart disease drug, the first time a developing country has torn up the international patent for such a treatment. In addition to the "compulsory license" of Plavix, made by...Bristol-Myers Squibb and Sanofi-Aventis, Bangkok approved a generic version of Abbott Laboratories' Kaletra, an HIV/AIDS treatment. [also refers to compulsory license on Merck drug]